PTHS

Conviction 74HealthcareScan · Thu, Jun 25, 2026

Hanging man

PTHS$28.73+0.07%

ResistanceSupportVol 14Insider sell

Vol MA14 23.54K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Pelthos Therapeutics Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.pelthos.com ↗

Price28.73

Change+0.07%

Gap+1.01%

Rel volume1.62×

Avg volume18.89K

Avg $ vol526.44K

SMA 2027.27

SMA 5026.06

SMA 20026.34

Price vs 50+10.26%

Price vs 200+9.05%

MA stackmixed

50/200 cross—

Supertrendup · 25.29

RSI (14)58

MACD hist0.13

MACD crossbull · 4d

Stoch %K / %D80 / 86

ADX (14)26

+DI / −DI28 / 19

RSI divergence—

MACD divergence—

ATR %+4.46%

ADR %3.62%

52w high37.42

52w low0.0000

From 52w high-23.22%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width18.88%

%B0.78

Donchian pos79.82%

Donchian high29.61

Donchian low25.25

AVWAP (52w high)27.51

vs AVWAP high+4.42%

AVWAP (52w low)25.81

vs AVWAP low+11.33%

OBV trendUp

Chaikin MF (20)0.13

Today vs 20d1.62×

Avg vol (14d)23.54K

Avg vol (20d)18.89K

Avg $ vol (20d)526.44K

Market cap99.86M

RS 3m (vs SPY)+18.24%

RS 6m (vs SPY)+4.28%

RS line new highNo

Trend template—

Technical rank70.0

1 week+6.37%

1 month+5.74%

3 months+30.06%

6 months+7.36%

1 year—

YTD-2.44%

P/E-2.31

P/B2.84

P/S5.95

P/FCF-4.40

EPS-23.04

Div yield—

ROE-123.41%

ROA-29.80%

Debt/Eq—

Current2.79

EV/EBITDA—

Gross margin—

Net margin-257.93%

Rev growth—

EPS growth-444.55%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value67.88M

Revenue10.91M

Net income-10.24M

Gross profit—

Free cash flow-22.69M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out3.48M

Employees92

ListedFri, Feb 16, 2024

Free float1.38M

Float %41.1%

Short interest38.11K

Days to cover1.6d

Short volume50.3%

Squeeze score30 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$3.09 vs −$4.00

Last surprise+22.8% beat

Setup gradeB

Conviction74 / 100

Pattern quality—

Tech rank70.0 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHanging man

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PTHS

All disclosures →

No recent disclosed trades by Congress in PTHS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PTHS · 1 buy · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Francis Knuettel II CFO, Treas & Secty · Common Stock · 2026-05-22	Sell	1.5K	$40K	2026-05-22	2026-05-26
Francis Knuettel II CFO, Treas & Secty · Stock Option · 2026-05-22	Grant	59.5K	—	2026-05-22	2026-05-26
Francis Knuettel II CFO, Treas & Secty · Stock Option · 2026-05-22	Disposition	42.5K	—	2026-05-22	2026-05-26
Francis Knuettel II CFO, Treas & Secty · Common Stock · 2026-05-22	Disposition	13.95K	$0	2026-05-22	2026-05-26
Francis Knuettel II CFO, Treas & Secty · Common Stock · 2026-05-22	Other	—	—	2026-05-22	2026-05-26
Friedberg Ezra M Director · Common Stock · 2026-05-14	Tax	144	$4K	2026-05-14	2026-05-18
Friedberg Ezra M Director · Common Stock · 2026-05-14	Other	—	—	2026-05-14	2026-05-18

SEC filings

EDGAR filings in PTHS

EDGAR →

No recent SEC filings on file for PTHS.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.